Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Debt Ratio (2023 - 2025)

Goldenwell Biotech (GWLL) has disclosed Debt Ratio for 3 consecutive years, with 0.5 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Debt Ratio changed N/A year-over-year to 0.5, compared with a TTM value of 0.5 through Mar 2025, changed N/A, and an annual FY2024 reading of 0.43, up 28.66% over the prior year.
  • Debt Ratio was 0.5 for Q1 2025 at Goldenwell Biotech, up from 0.43 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.5 in Q1 2025 and bottomed at 0.33 in Q4 2023.
  • Average Debt Ratio over 3 years is 0.42, with a median of 0.43 recorded in 2024.
  • Peak annual rise in Debt Ratio hit 28.66% in 2024, while the deepest fall reached 28.66% in 2024.
  • Year by year, Debt Ratio stood at 0.33 in 2023, then increased by 28.66% to 0.43 in 2024, then grew by 16.82% to 0.5 in 2025.
  • Business Quant data shows Debt Ratio for GWLL at 0.5 in Q1 2025, 0.43 in Q4 2024, and 0.33 in Q4 2023.